Table 3. Sensitivity at 95% specificitya of the structural and functional parameters to diagnose glaucoma.
Sector | GCIPL thickness | SAP sensitivity | MP sensitivity | P_1 | P_2 | P_3 |
---|---|---|---|---|---|---|
Superotemporal | 59% (41–77) | 20% (05–49) | 21% (12–39) | <0.001 | <0.001 | 0.85 |
Superior | 38% (18–58) | 21% (07–41) | 11% (03–27) | 0.001 | <0.001 | 0.01 |
Superonasal | 31% (16–49) | 16% (06–35) | 08% (02–19) | 0.001 | <0.001 | 0.02 |
Inferonasal | 41% (11–63) | 18% (03–40) | 30% (18–48) | <0.001 | 0.06 | 0.04 |
Inferior | 57% (26–76) | 34% (13–54) | 38% (23–60) | <0.001 | 0.002 | 0.52 |
Inferotemporal | 43% (16–77) | 31% (14–53) | 33% (18–50) | 0.04 | 0.10 | 0.74 |
Average | 51% (33–71) | 25% (02–40) | 16% (06–30) | <0.001 | <0.001 | 0.06 |
Abbreviations: GCIPL, ganglion cell-inner plexiform layer; SAP, standard automated perimetry; MP, microperimetry; P_1, P-value associated with the comparison of the sensitivities between GCIPL and SAP parameters; P_2, P-value associated with the comparison of the sensitivities between GCIPL and MP parameters; P_3, P-value associated with the comparison of the sensitivities between SAP and MP parameters.
95% Confidence intervals within parentheses.